1. Highlights of the 2004 scientific sessions of the Heart Failure Society of America, Toronto, Canada, September 12 to 15, 2004;Aaronson;Journal of the American College of Cardiology,2005
2. Clinical trials update from the Heart Failure Society of America: EMOTE, HERB-CHF, BEST genetic sub-study and RHYTHM-ICD;Lalukota;European Journal of Heart Failure,2004
3. Alexander HA Clinical effects of Crataegus extract LI132 for treating heart insufficiency stage 2 New York Heart Association. A randomised placebo-controlled double-blind study with n=73 patients Dissertation (Dr. med), Charité University Medical Centre, Berlin, Germany 1995
4. Effectiveness of hawthorn extract at a dosage of 3 x 100 mg per day. Multicentre double-blind trial with 85 NYHA stage II heart failure patients;Bödigheimer;Munchener Medizinische Wochenschrift,1994
5. Effectiveness of and tolerance to Crataegus extract WS1442 in patients with heart insufficiency and reduced leftventricular function;Eichstädt;Perfusion,2001